Literature DB >> 9246571

Bradykinin antagonizes the effects of alpha-thrombin.

W D Ehringer1, M J Edwards, R D Gray, F N Miller.   

Abstract

alpha-Thrombin (AT) and bradykinin (BK) are endogenous mediators that are released during an inflammatory response, and could have a synergistic effect on endothelial permeability. Human umbilical vein endothelial cells (HUVEC) were grown on Transwell membranes and then tested for alterations in permeability to fluorescein isothiocyanate-labeled human serum albumin. Addition of 1 microM AT produced a significant increase in the permeability coefficient at 30 minutes from control levels of 1.59 x 10(-6) cm/sec to 4.92 x 10(-6) cm/sec. BK (1 microM) produced a similar increase to 4.46 x 10(-6) cm/sec. For both compounds, permeability remained elevated for 90 minutes. Pre-treatment of the HUVEC with the bradykinin receptor antagonist, Na-adamantaneacetyl-bradykinin (NA-BK) (1 microM), prior to addition of AT, reduced the AT permeability coefficient to 2.69 x 10(-6) cm/sec. Addition of NA-BK (1 microM) for 5 minutes, then BK (1 microM) for 5 minutes, inhibited the effect of BK and of AT (1 microM on permeability, decreasing the permeability coefficient of the endothelial monolayer to control levels (1.62 x 10(-6) cm/sec). AT (1 microM) increased HUVEC intracellular calcium mobilization, as monitored by FURA-2, to 245 nM from control (70 nM), however, pre-treatment with either BK or the bradykinin receptor antagonist decreased the AT induced intracellular calcium mobilization compared to AT alone. Pre-treatment of the HUVEC with bradykinin (1 microM) for 2 minutes also inhibited the effects of alpha-thrombin (1 microM) on f-actin distribution examined by BODIPY-phallodin staining and increased the clotting times for an alpha-thrombin dependent fibrinogen to fibrin clotting assay. However, incubation of bradykinin (1 microM) with alpha-thrombin (1 microM) for either 10 minutes or 100 minutes produced no detectable hydrolysis products. These data strongly suggest that the inflammatory mediators alpha-thrombin and bradykinin when released together, rather than being synergistic, are antagonistic.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246571     DOI: 10.1023/a:1027345832138

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

1.  Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin.

Authors:  J M Maraganore; P Bourdon; J Jablonski; K L Ramachandran; J W Fenton
Journal:  Biochemistry       Date:  1990-07-31       Impact factor: 3.162

2.  Intravital and electron microscopic study of bradykinin-induced vascular permeability changes using FITC-dextran as a tracer.

Authors:  D Hulström; E Svensjö
Journal:  J Pathol       Date:  1979-11       Impact factor: 7.996

Review 3.  Active site and exosite binding of alpha-thrombin.

Authors:  A Tulinsky; X Qiu
Journal:  Blood Coagul Fibrinolysis       Date:  1993-04       Impact factor: 1.276

Review 4.  Modulation of venular microvessel permeability by calcium influx into endothelial cells.

Authors:  F E Curry
Journal:  FASEB J       Date:  1992-04       Impact factor: 5.191

5.  Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers.

Authors:  J E Stasek; C E Patterson; J G Garcia
Journal:  J Cell Physiol       Date:  1992-10       Impact factor: 6.384

Review 6.  A player of many parts: the spotlight falls on thrombin's structure.

Authors:  M T Stubbs; W Bode
Journal:  Thromb Res       Date:  1993-01-01       Impact factor: 3.944

7.  Tumor necrosis factor and the acute metabolic response to tissue injury in man.

Authors:  H F Starnes; R S Warren; M Jeevanandam; J L Gabrilove; W Larchian; H F Oettgen; M F Brennan
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

8.  Time course of thrombin-induced increase in endothelial permeability: relationship to Ca2+i and inositol polyphosphates.

Authors:  H Lum; J L Aschner; P G Phillips; P W Fletcher; A B Malik
Journal:  Am J Physiol       Date:  1992-08

9.  Canine jugular vein endothelial cell monolayers in vitro: vasomediator-activated diffusive albumin pathway.

Authors:  D O DeFouw; K L Brown; R N Feinberg
Journal:  J Vasc Res       Date:  1993 May-Jun       Impact factor: 1.934

10.  Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation.

Authors:  Z M Goeckeler; R B Wysolmerski
Journal:  J Cell Biol       Date:  1995-08       Impact factor: 10.539

View more
  4 in total

Review 1.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

2.  Bradykinin and alpha-thrombin increase human umbilical vein endothelial macromolecular permeability by different mechanisms.

Authors:  W D Ehringer; O L Wang; A Haq; F N Miller
Journal:  Inflammation       Date:  2000-04       Impact factor: 4.092

3.  Genetic effects of BDKRB2 and KNG1 on deep venous thrombosis after orthopedic surgery and the potential mediator.

Authors:  Qingfeng Wang; Guoping Cheng; Xiaohui Wang; Dandan Wang; Yanmei Yang; Ke Chen; Jiumin Ye; Zhong Qing
Journal:  Sci Rep       Date:  2018-11-26       Impact factor: 4.379

4.  Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation.

Authors:  My-Linh Ngo; Fakhri Mahdi; Dhaval Kolte; Zia Shariat-Madar
Journal:  J Inflamm (Lond)       Date:  2009-01-27       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.